OLD National Bancorp IN trimmed its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 90.4% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 5,968 shares of the exchange traded fund’s stock after selling 56,104 shares during the period. OLD National Bancorp IN’s holdings in SPDR S&P Biotech ETF were worth $762,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in XBI. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth about $27,000. Intesa Sanpaolo Wealth Management purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $30,000. SHP Wealth Management purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $31,000. Legacy Wealth Managment LLC ID acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth approximately $32,000. Finally, Smartleaf Asset Management LLC acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth approximately $32,000.
SPDR S&P Biotech ETF Stock Up 2.5%
NYSEARCA:XBI opened at $155.38 on Friday. The company has a market cap of $9.91 billion, a P/E ratio of 11.47 and a beta of 0.85. The firm’s 50 day moving average is $135.24 and its two-hundred day moving average is $128.70. SPDR S&P Biotech ETF has a fifty-two week low of $82.04 and a fifty-two week high of $155.93.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
